Khan Sehat Limited Pharmaceutical Import Profile — Afghanistan (DGFT 2022–2026)

Name: Khan Sehat Limited Pharmaceutical Import Records from India — 5 Products, $1.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Khan Sehat Limited — Pharmaceutical Importer Profile (2026) | 5 Products, $1.8M Trade | TransData Nexus

Khan Sehat Limited

Pharmaceutical Importer · Afghanistan · Advanced Antibiotics Focus · $1.8M Total Trade · DGFT Verified

Khan Sehat Limited is a pharmaceutical importer based in Afghanistan with a total trade value of $1.8M across 5 products in 3 therapeutic categories. Based on 36 verified import shipments from Indian Customs (DGFT) records, Khan Sehat Limited is the #1 buyer in 1 product including Amikacin. Khan Sehat Limited sources from 8 verified Indian suppliers, with Combitic Global Caplet Private Limited accounting for 44.5% of imports.

Khan Sehat Limited — Import Portfolio & Supplier Network

Khan Sehat Limited import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Khan Sehat Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Combitic Global Caplet Private Limited	$1.0M	85	44.5%
Unimax Laboratories	$804.7K	230	35.2%
Synokem Pharmaceuticals Limited	$130.5K	20	5.7%

What Formulations Does Khan Sehat Limited Import?

Formulation	Value	Ships
Omeprazole capsule i.p. 20MG grucid	$216.1K	6
Sildenafil citrate tablets IP 100MG.	$81.5K	4
Sildenafil citrate tablet black	$80.5K	6
Omeprazole capsule i.p. 20MG grucid capsule batch : gc-2972 to gc-2998 gc-3001 as per document	$50.0K	1
Paracetamol phenylephrine	$50.0K	1
Alprazolam tablet IP 0.5 MG aximax tablet batch : axm-119 to axm-132 axm-138as per document	$50.0K	1
Alprazolam tablet IP 0.5 MG (aximax tablet) batch : axm-119 to axm-132 axm-138as per invoice	$50.0K	1
Omeprazole capsule i.p. 20MG grucid capsule batch : gc-2933 to gc-2951 gc-2920 as per document	$46.5K	1
Omeprazole capsule i.p. 20MG grucid capsule batch : gc-2949 to gc-2971 gc-2938 gc-2946 gc-2947 as per document attd.	$46.4K	1
Ciprofloxacin tablet IP 500 MG batch	$44.6K	2
Ciprofloxacin hydrochloride tablets IP 750 MG sifloks 750 batch : sfl7-13 tosfl7-15 as per document	$35.6K	1
Pantoprazole and domperidone tablets	$26.9K	5
Domperidone 10 MG and lansoprazole 30 MG	$26.7K	4
Sildenafil citrate tablets IP 100MG. cobra 150 batch : cbt-226 to cbt-233 as per document	$23.2K	1
Sildenafil citrate tablet black cobra-125 batch : bcb-61 to bcb-66 as per document	$20.1K	1

Khan Sehat Limited imports 338 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ceftriaxone	Advanced Antibiotics	$750.0K	15	0.3%	6
2	Zinc	Vitamins & Supplements	$450.0K	9	0.6%	15
3	Amikacin	Advanced Antibiotics	$300.0K	6	1.4%	1
4	Ornidazole	Advanced Antibiotics	$200.0K	4	1.1%	5
5	Alprazolam	CNS & Psychiatric	$100.0K	2	0.6%	14

Khan Sehat Limited imports 5 pharmaceutical products across 3 categories into Afghanistan totaling $1.8M. The company is the #1 buyer for 1 product: Amikacin.

Khan Sehat Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Khan Sehat Limited, established in Kabul in 2007 as Khan Global Pharmacies, transitioned to its current form in 2011, focusing on importing pharmaceutical products from India. The company has grown to become one of Afghanistan's leading pharmaceutical importers, emphasizing high-quality, cost-effective medications. Its mission is to provide accessible and affordable healthcare solutions, aiming to be the leading healthcare provider in Afghanistan. (khansehat.af)

Headquartered in Shah Shaheed, Kabul, opposite Chamane Huzori, Khan Sehat Limited operates a significant distribution network across Afghanistan. The company collaborates with renowned Indian pharmaceutical manufacturers, including Unimax Laboratories, Intermed Laboratories Private Limited, Lincoln Pharmaceuticals Limited, Torque Pharmaceuticals, and Vee Excel Drugs Pharmaceuticals Pvt Ltd. (khansehat.af)

2Distribution Network

Khan Sehat Limited's distribution network is centralized at its headquarters in Kabul, with a warehouse located in Shah Shaheed, opposite Chamane Huzori. The company ensures the availability of a diverse range of pharmaceutical products across Afghanistan, addressing common health challenges through customized treatment solutions. (khansehat.af)

3Industry Role

Khan Sehat Limited serves as a primary wholesaler and importer in Afghanistan's pharmaceutical supply chain. By sourcing medications from reputable Indian manufacturers, the company plays a crucial role in ensuring the availability of quality medicines throughout the country. Its extensive distribution network facilitates the delivery of essential pharmaceuticals to various healthcare providers and pharmacies. (khansehat.af)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Khan Sehat Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Khan Sehat Limited's sourcing strategy is highly concentrated, with a significant portion of its imports originating from a select group of Indian suppliers. The company's total import value from India stands at $1.8 million USD, with 36 shipments across five products. The top five products imported include Amikacin ($300K), Zinc ($450K), Ceftriaxone ($750K), Ornidazole ($200K), and Alprazolam ($100K). The primary suppliers are Unimax Laboratories ($805K, 35.2% of total imports) and Combitic Global Caplet Private Limited ($1.0M, 44.5% of total imports). (khansehat.af)

This high supplier concentration indicates a strategic choice to maintain strong relationships with key manufacturers, ensuring consistent quality and supply. However, it also presents a risk; any disruption with these suppliers could significantly impact Khan Sehat Limited's operations. The company's reliance on a limited number of suppliers suggests a need for diversification to mitigate potential supply chain vulnerabilities.

2Supply Chain Resilience

Khan Sehat Limited's supply chain resilience is closely tied to its partnerships with key Indian suppliers. The company's top suppliers, Unimax Laboratories and Combitic Global Caplet Private Limited, are established entities with a history of consistent product quality and supply. Unimax Laboratories, for instance, is WHO-GMP certified and has been exporting to Afghanistan for over a decade. (khansehat.af)

Importing Pharmaceuticals into Afghanistan — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Afghanistan

1Regulatory Authority & Framework

The Afghanistan Food and Drug Authority (AFDA) is the primary regulatory body overseeing the pharmaceutical sector in Afghanistan. Established to address challenges related to the quality and safety of pharmaceuticals, the AFDA is responsible for regulating medicines, medical devices, vaccines, diagnostics, and other health products. (afda.gov.af)

Key legislation governing pharmaceutical imports includes the National Medicine and Health Products Regulatory Authority (NMHRA) guidelines, which outline the procedures for importing and marketing pharmaceutical products. The NMHRA maintains a National Licensed Medicines List, detailing all items allowable for importation and commercialization in the private sector. (platform.who.int)

The marketing authorization pathway for Indian generics involves obtaining a certificate for each product, ensuring that the active substance corresponds with an item listed in the NMHRA's Licensed Medicine List. This process requires sufficient proof of adequate quality control measures, as per the WHO Certification Scheme on the Quality of Pharmaceutical Products moving in International Commerce. (platform.who.int)

2Import Licensing & GMP

Import licensing requirements in Afghanistan stipulate that all entities wishing to import medicines must obtain an activity license from the General Directorate of Pharmacy Affairs (GDPA) under the Ministry of Public Health (MoPH). Additionally, an import permit from the GDPA is required. Only medicines registered in the National Licensed Medicines List are permitted for importation.

Khan Sehat Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Khan Sehat Limited's product strategy focuses on therapeutic areas that address prevalent health issues in Afghanistan. The company's imports are primarily in advanced antibiotics (69.4%), vitamins and supplements (25.0%), and CNS & psychiatric medications (5.6%). This focus aligns with the country's health priorities, aiming to combat infectious diseases, nutritional deficiencies, and mental health challenges. (khansehat.af)

The market demand for these products is driven by the high incidence of bacterial infections, malnutrition, and mental health disorders in Afghanistan. By concentrating on these therapeutic areas, Khan Sehat Limited addresses critical healthcare needs, positioning itself as a key player in improving public health outcomes.

2Sourcing Profile

Khan Sehat Limited's sourcing strategy emphasizes importing finished pharmaceutical formulations from India, focusing on generic drugs. The company's portfolio includes a diverse range of formulations, with 338 unique products imported. This approach allows Khan Sehat Limited to offer a wide array of medications, catering to various therapeutic needs. (khansehat.af)

India's well-established pharmaceutical industry, characterized by its adherence to international quality standards and competitive pricing, makes it an ideal sourcing partner for Khan Sehat Limited. The company's preference for finished formulations ensures that imported products are ready for distribution, streamlining the supply chain and reducing time to market.

Frequently Asked Questions — Khan Sehat Limited

What products does Khan Sehat Limited import from India?

Khan Sehat Limited imports 5 pharmaceutical products across 3 categories. Top imports: Ceftriaxone ($750.0K), Zinc ($450.0K), Amikacin ($300.0K), Ornidazole ($200.0K), Alprazolam ($100.0K).

Who supplies pharmaceuticals to Khan Sehat Limited from India?

Khan Sehat Limited sources from 8 verified Indian suppliers. The primary supplier is Combitic Global Caplet Private Limited (44.5% of imports, $1.0M).

What is Khan Sehat Limited's total pharmaceutical import value?

Khan Sehat Limited's total pharmaceutical import value from India is $1.8M, based on 36 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Khan Sehat Limited focus on?

Khan Sehat Limited imports across 3 categories. The largest: Advanced Antibiotics (69.4%), Vitamins & Supplements (25.0%), CNS & Psychiatric (5.6%).

Get Full Khan Sehat Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Khan Sehat Limited

Khan Sehat Limited — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Khan Sehat Limited?

What Formulations Does Khan Sehat Limited Import?

What Products Does Khan Sehat Limited Import?

Top Products by Import Value

Khan Sehat Limited Therapeutic Categories — 3 Specializations